ENZON PHARMACEUTICALS, INC. financial data

Symbol
ENZN on OTC
Location
Cranford, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 6725% % 9.4%
Return On Equity 1283% % 4889%
Return On Assets -7.7% % -567%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74,214,603 shares 0%
Common Stock, Shares, Outstanding 74,214,603 shares 0%
Entity Public Float $4,921,536 USD -28%
Common Stock, Value, Issued $742,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 74,215,000 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 74,215,000 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $26,000 USD
Operating Income (Loss) $5,311,000 USD -300%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,390,000 USD -401%
Income Tax Expense (Benefit) $19,000 USD -95%
Net Income (Loss) Attributable to Parent $3,409,000 USD -538%
Earnings Per Share, Basic -0.07 USD/shares -600%
Earnings Per Share, Diluted -0.07 USD/shares -600%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $42,574,000 USD -9.1%
Other Assets, Current $239,000 USD -18%
Assets, Current $42,813,000 USD -9.2%
Deferred Income Tax Assets, Net $26,000 USD -92%
Assets $42,813,000 USD -9.2%
Accounts Payable, Current $331,000 USD 0%
Accrued Liabilities, Current $400,000 USD 456%
Liabilities, Current $731,000 USD -56%
Retained Earnings (Accumulated Deficit) $73,301,000 USD -4.9%
Stockholders' Equity Attributable to Parent $2,525,000 USD -184%
Liabilities and Equity $42,813,000 USD -9.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $618,000 USD -346%
Net Cash Provided by (Used in) Financing Activities $1,275,000 USD 0%
Common Stock, Shares Authorized 170,000,000 shares 0%
Common Stock, Shares, Issued 74,214,603 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,893,000 USD -85%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $42,574,000 USD -9.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $29,709,000 USD -8.3%
Deferred Tax Assets, Gross $29,709,000 USD -8.3%
Deferred Income Tax Expense (Benefit) $17,000 USD -95%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2,960,000 shares 0%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) $2,000 USD 0%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%